 |
| |
| Mar-06-19 | Initiated |
National Securities |
Buy |
$35 |
|
| Dec-17-18 | Upgrade |
Goldman |
Neutral → Buy |
|
|
| Sep-07-18 | Initiated |
Goldman |
Neutral |
|
|
| Dec-20-17 | Initiated |
Ladenburg Thalmann |
Buy |
$34.25 |
|
| Sep-27-17 | Downgrade |
Citigroup |
Buy → Neutral |
|
|
| Aug-15-17 | Initiated |
Citigroup |
Buy |
$16 |
|
| Aug-14-17 | Initiated |
Wells Fargo |
Outperform |
$17 |
|
| Aug-14-17 | Initiated |
Jefferies |
Buy |
$16 |
|
|
|
| Apr-12-19 10:41AM | US-China Trade Talks to Influence Agriculture Operations Outlook Zacks |
| Mar-21-19 10:00AM | Archer Daniels' Cost Savings & Project Readiness Bode Well Zacks |
| Mar-12-19 11:30PM | Gene-edited food quietly arrives in restaurant cooking oil Associated Press |
| 11:30PM | Gene-edited food quietly arrives in restaurant cooking oil Associated Press |
| Mar-11-19 06:00PM | Calyxt (CLXT) Reports Q4 Loss, Lags Revenue Estimates Zacks +5.30% |
| 04:10PM | Calyxt Reports 4th Quarter and Full Year 2018 Financial Results Business Wire |
| Mar-05-19 04:30PM | Calyxt to Hold Fourth Quarter and Full-Year 2018 Investor Conference Call on Tuesday, March 12, at 8:30 a.m. EDT 7:30 a.m. CDT Business Wire |
| Feb-26-19 04:30PM | First Commercial Sale of Calyxt High Oleic Soybean Oil on the U.S. Market Business Wire |
| Feb-19-19 06:54PM | Calyxt and Agtegra Cooperative Announce Strategic Collaboration to Distribute Calyxt High Oleic Soybean Business Wire |
| Feb-11-19 07:45AM | Consolidated Research: 2019 Summary Expectations for Granite Point Mortgage Trust, Brandywine Realty Trust, Kraton, Century Aluminum, Rudolph Technologies, and Calyxt Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Feb-10-19 12:00AM | [$$] Gene editing: how agritech is fighting to shape the food we eat Financial Times |
| Jan-28-19 04:30PM | Calyxt Names Debra Frimerman as General Counsel Business Wire |
| Jan-23-19 05:00PM | Kimberly Nelson Appointed to Calyxt Board of Directors Business Wire |
| Jan-22-19 05:30PM | Calyxt Doubles 2018 High Oleic Soybean Acres Business Wire |
| 03:15PM | Can Clorox's Strategic Growth Efforts Offset Margin Issues? Zacks |
| 08:48AM | Archer Daniels Rides on Solid Cost Saving & Readiness Efforts Zacks |
| Jan-03-19 04:30PM | Calyxt Appoints Veteran Finance Executive, William F. Koschak, as Chief Financial Officer Business Wire |
| Dec-21-18 09:36AM | When Can We Expect A Profit From Calyxt, Inc. (NASDAQ:CLXT)? Simply Wall St. -14.32% |
| Dec-17-18 04:30PM | Calyxt Receives EU Patent on Use of CRISPR/Cas9 for Genome Editing in Plants Business Wire +23.79% |
| 07:58AM | The Zacks Analyst Blog Highlights: Archer-Daniels, Monster Beverage, Blue Apron, Calyxt and Ollie's Zacks |
| Dec-14-18 08:37AM | 5 Top Consumer Staples to Buy Stocks Amid a Volatile Market Zacks |
| Dec-12-18 08:31PM | [$$] U.S. Soybean Farmers Work to Loosen Chinas Grip The Wall Street Journal |
| Nov-26-18 08:55AM | Report: Exploring Fundamental Drivers Behind Reata Pharmaceuticals, Calyxt, SIFCO Industries, EchoStar, Tel-Instrument Electronics, and United States Antimony New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire |
| Nov-13-18 05:40PM | Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates Zacks |
| 04:37PM | Calyxt: 3Q Earnings Snapshot Associated Press |
| 04:30PM | Calyxt Reports Financial Results for Third Quarter 2018 Business Wire |
| Nov-05-18 04:46PM | Calyxt to Hold Third Quarter 2018 Investor Conference Call on Wednesday, November 14, at 8 a.m. EST 7 a.m. CST Business Wire |
| 10:30AM | Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know Zacks |
| Oct-15-18 04:30PM | Calyxt Hires Former Cargill Supply Chain Manager Business Wire -6.30% |
| Oct-10-18 04:30PM | Calyxt Harvests High-Fiber Wheat Field Trials Business Wire -7.58% |
| Oct-09-18 07:45AM | Consolidated Research: 2018 Summary Expectations for LaSalle Hotel Properties, EchoStar, Clean Energy Fuels, Innophos, Data I/O, and Calyxt Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Oct-05-18 06:00AM | Gene-Edited Foods Are Coming to Your Plate But Arent Being Regulated Bloomberg |
| Oct-04-18 04:30PM | Calyxt Inks Agreement with KemX Global to Refine High-Oleic Soybean Oil Business Wire |
| Sep-27-18 04:30PM | Calyxt Signs Agreement with American Natural Processors to Crush and Process its High-Oleic Soybeans Business Wire |
| Sep-18-18 04:30PM | Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP Business Wire |
| Sep-17-18 04:30PM | Christopher J. Neugent, a Leader of the Food Industry, Joins Calyxt Board of Directors Business Wire |
| Aug-23-18 06:30PM | Calyxt to Present at Wells Fargo Securities Agribusiness Panel Business Wire |
| Aug-22-18 08:00AM | Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO Business Wire |
| Aug-10-18 09:50AM | Gene-editing startups ignite the next 'Frankenfood' fight Reuters |
| 02:03AM | Insight: Gene-editing startups ignite the next 'Frankenfood' fight Reuters |
| Aug-02-18 07:55AM | Factors of Influence in 2018, Key Indicators and Opportunity within MTS, First Financial Bankshares, Tribune Media, Calyxt, McGrath RentCorp, and NorthWestern New Research Emphasizes Economic Growth GlobeNewswire |
| 07:30AM | Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates Zacks |
| 05:08AM | Calyxt: 2Q Earnings Snapshot Associated Press |
| Aug-01-18 06:13PM | Calyxt Reports Financial Results for Second Quarter and Half-Year 2018 Business Wire |
| Jul-30-18 07:30AM | Market Trends Toward New Normal in McDonald's, Calyxt, Ultra Petroleum, Crocs, The Progressive, and AmerisourceBergen Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Jul-20-18 03:06AM | Battle lines drawn as EU court weighs fate of gene-edited crops Reuters |
| Jul-19-18 08:00AM | Calyxt and S&W Seed Company Announce Milestone in Alfalfa Seed Development Program Business Wire |
| Jul-12-18 10:09AM | Zacks Industry Outlook Highlights: Archer Daniels Midland, Calyxt and Adecoagro Zacks |
| Jul-11-18 05:32AM | Calyxt Sees Hammer Chart Pattern: Time to Buy? Zacks |
| May-23-18 07:30AM | Report: Developing Opportunities within MFA Financial, Stewart Information Services, Eagle Bulk Shipping, Monmouth Real Estate Investment, Granite Point Mortgage Trust, and Calyxt Future Expectations, Projections Moving into 2018 GlobeNewswire |
| May-22-18 04:00PM | Calyxt Announces Successful Closing of $60.9 Million Public Offering Business Wire |
| May-21-18 08:30AM | Cellectis S.A.: Calyxt Announces Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire |
| May-15-18 05:50PM | Calyxt Announces Launch of Proposed Follow-On Offering Business Wire |
| 04:41PM | Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court Business Wire |
| May-07-18 06:21PM | Calyxt: 1Q Earnings Snapshot Associated Press |
| 04:30PM | Calyxt Reports Financial Results for First Quarter 2018 Business Wire |
| Apr-25-18 05:00PM | Calyxt to Hold First Quarter 2018 Investor Conference Call on Tuesday, May 8, at 8 a.m. EDT 7 a.m. CDT Business Wire |
| Apr-05-18 05:00PM | Calyxt Exceeds Farmer Adoption Milestone for High-Oleic Soybean Product Launch Business Wire |
| Mar-30-18 08:25AM | Consolidated Research: 2018 Summary Expectations for RadNet, Molecular Templates, Federated Investors, Kadant, Heartland Financial, and Calyxt Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Mar-21-18 04:30PM | Calyxts High Fiber Wheat Deemed Non-Regulated by USDA Business Wire |
| Mar-13-18 06:45PM | Calyxt Reports Financial Results for Fourth Quarter and Full-Year 2017 Business Wire |
| Mar-12-18 08:34PM | Calyxt Filed Complaint in Delaware Chancery Court Against Bayer CropScience, LP Business Wire |
| Mar-05-18 04:30PM | Calyxt to Hold Fourth Quarter and Full-Year 2017 Investor Conference Call on Wednesday, March 14, at 8 a.m. EDT 7 a.m. CDT Business Wire |
| Mar-01-18 08:00AM | Calyxt Expands Total Acreage with Farmers for High-Oleic Soybean Product Business Wire |
| Jan-30-18 07:30AM | Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Dec-12-17 04:30PM | Calyxt and Farmers Business Network, Inc. Partner to Expand Grower Base for Calyxts Identity-Preserved High Oleic Soybeans Business Wire +5.23% |
| Nov-13-17 04:29PM | Calyxt Reports Financial Results for Third Quarter and First Nine Months of 2017 Business Wire |
| Nov-08-17 01:58PM | Calyxt, Inc. breached its 50 day moving average in a Bearish Manner : CLXT-US : November 8, 2017 Capital Cube |
| Oct-02-17 08:00AM | Calyxt and S&Ws Gene-Edited Alfalfa Plant Designated as Non-Regulated by USDA Business Wire +7.80% |
| Sep-25-17 04:45PM | Calyxt to Present at the Ladenburg Thalmann 2017 Healthcare Conference Business Wire |
| 04:30PM | Calyxt Advances Herbicide-Tolerant Wheat and Improved Oil Composition Canola Product Candidates to Phase 1 Business Wire |
| 07:00AM | Earnings Review and Free Research Report: Calyxt Reported First Quarterly Results Post its IPO ACCESSWIRE |
| Sep-06-17 06:42PM | Calyxt to Break Ground on New Concept-to-Fork Facility in Roseville, Minn. Business Wire +5.57% |
| Jul-25-17 04:01PM | Calyxt Announces Full Exercise of Over-Allotment Option and Closing of its Initial Public Offering Business Wire |
| Jul-23-17 10:36AM | IPOs This Week: Real Estate Unicorn Redfin Leads Weeks IPOs 24/7 Wall St. |
| Jul-20-17 02:12PM | Minnesota Gene-Editing Company Calyxt Enters the Market With a Bang 24/7 Wall St. |
| 12:00PM | Calyxt Inc. shares soar in gene-editing company's market debut MarketWatch |
|
|
|
|
| Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. operates as a subsidiary of Cellectis S.A. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Blome James | Chief Executive Officer | Apr 02 | Sale | 16.65 | 2,582 | 42,982 | 154,136 | Apr 04 04:07 PM | | Sahoo Manoj | Chief Commercial Officer | Apr 01 | Sale | 17.33 | 1,522 | 26,378 | 66,817 | Apr 02 08:38 AM | | Blome James | Chief Executive Officer | Mar 26 | Sale | 17.87 | 2,582 | 46,129 | 156,718 | Mar 27 04:22 PM | | Sahoo Manoj | Chief Commercial Officer | Mar 20 | Sale | 18.00 | 3,262 | 58,716 | 68,339 | Mar 21 04:07 PM | | Sahoo Manoj | Chief Commercial Officer | Mar 19 | Sale | 18.00 | 5,068 | 91,224 | 71,601 | Mar 21 04:07 PM | | Blome James | Chief Executive Officer | Mar 19 | Sale | 17.32 | 2,582 | 44,713 | 159,300 | Mar 20 09:26 PM | | Ribeill Yves J | Director | Mar 14 | Sale | 16.33 | 4,980 | 81,317 | 40,020 | Mar 15 04:01 PM | | Ribeill Yves J | Director | Mar 13 | Sale | 16.08 | 5,000 | 80,410 | 45,000 | Mar 15 04:01 PM | | Blome James | Chief Executive Officer | Mar 12 | Sale | 16.58 | 2,582 | 42,802 | 161,882 | Mar 15 04:03 PM | | Ribeill Yves J | Director | Mar 12 | Sale | 16.76 | 5,000 | 83,819 | 50,000 | Mar 15 04:01 PM | | Ribeill Yves J | Director | Mar 11 | Sale | 17.39 | 5,000 | 86,958 | 55,000 | Mar 15 04:01 PM | | Voytas Daniel F | Chief Science Officer | Feb 25 | Option Exercise | 3.59 | 3,977 | 14,277 | 96,959 | Feb 26 06:44 PM | | Voytas Daniel F | Chief Science Officer | Feb 25 | Sale | 16.00 | 3,977 | 63,632 | 92,982 | Feb 26 06:44 PM | | Dumont Philippe | Director | Jan 04 | Sale | 12.00 | 1,117 | 13,404 | 17,060 | Jan 08 04:09 PM | | Sahoo Manoj | Chief Commercial Officer | Jan 02 | Sale | 10.39 | 2,444 | 25,389 | 76,669 | Jan 04 04:03 PM | | Voytas Daniel F | Chief Science Officer | Dec 18 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Dec 20 04:16 PM | | Voytas Daniel F | Chief Science Officer | Dec 18 | Sale | 13.00 | 4,083 | 53,079 | 92,982 | Dec 20 04:16 PM | | Voytas Daniel F | Chief Science Officer | Nov 08 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Nov 13 08:59 AM | | Voytas Daniel F | Chief Science Officer | Nov 08 | Sale | 13.00 | 4,083 | 53,079 | 92,982 | Nov 13 08:59 AM | | Voytas Daniel F | Chief Science Officer | Oct 09 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Oct 11 04:04 PM | | Voytas Daniel F | Chief Science Officer | Oct 09 | Sale | 13.84 | 4,083 | 56,514 | 92,982 | Oct 11 04:04 PM | | Dumont Philippe | Director | Oct 05 | Sale | 14.11 | 1,117 | 15,765 | 18,177 | Oct 09 04:14 PM | | Sahoo Manoj | Chief Commercial Officer | Oct 01 | Sale | 14.84 | 2,521 | 37,416 | 79,113 | Oct 03 06:25 PM | | Voytas Daniel F | Chief Science Officer | Sep 20 | Option Exercise | 3.59 | 4,666 | 16,751 | 97,648 | Sep 21 04:09 PM | | Voytas Daniel F | Chief Science Officer | Sep 20 | Sale | 16.00 | 4,666 | 74,656 | 92,982 | Sep 21 04:09 PM | | Voytas Daniel F | Chief Science Officer | Sep 10 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Sep 11 05:20 PM | | Voytas Daniel F | Chief Science Officer | Sep 10 | Sale | 16.13 | 4,083 | 65,842 | 92,982 | Sep 11 05:20 PM | | Voytas Daniel F | Chief Science Officer | Aug 20 | Option Exercise | 3.59 | 4,666 | 16,751 | 97,648 | Aug 22 04:58 PM | | Voytas Daniel F | Chief Science Officer | Aug 20 | Sale | 17.31 | 4,666 | 80,768 | 92,982 | Aug 22 04:58 PM | | Voytas Daniel F | Chief Science Officer | Aug 08 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Aug 10 02:22 PM | | Voytas Daniel F | Chief Science Officer | Aug 08 | Sale | 17.48 | 4,083 | 71,372 | 92,982 | Aug 10 02:22 PM | | Voytas Daniel F | Chief Science Officer | Jul 20 | Option Exercise | 3.59 | 4,666 | 16,751 | 97,648 | Jul 24 08:03 PM | | Voytas Daniel F | Chief Science Officer | Jul 20 | Sale | 17.94 | 4,666 | 83,708 | 92,982 | Jul 24 08:03 PM | | Voytas Daniel F | Chief Science Officer | Jul 09 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Jul 11 04:08 PM | | Voytas Daniel F | Chief Science Officer | Jul 09 | Sale | 17.84 | 4,083 | 72,822 | 92,982 | Jul 11 04:08 PM | | Godard Alain | Director | Jun 21 | Sale | 20.84 | 5,880 | 122,540 | 33,320 | Jun 25 02:57 PM | | Arbadji Michel | Director of Business Developme | Jun 20 | Option Exercise | 3.59 | 6,500 | 23,321 | 31,490 | Jun 22 03:49 PM | | Voytas Daniel F | Chief Science Officer | Jun 20 | Option Exercise | 3.59 | 4,666 | 16,751 | 97,648 | Jun 22 03:53 PM | | Arbadji Michel | Director of Business Developme | Jun 20 | Sale | 22.00 | 6,500 | 143,000 | 24,990 | Jun 22 03:49 PM | | Voytas Daniel F | Chief Science Officer | Jun 20 | Sale | 20.56 | 4,666 | 95,910 | 92,982 | Jun 22 03:53 PM | | Sahoo Manoj | Chief Commercial Officer | Jun 18 | Sale | 20.51 | 490 | 10,050 | 81,634 | Jun 19 03:08 PM | | Cellectis S.A. | 10% Owner | Jun 15 | Buy | 19.49 | 63,175 | 1,231,281 | 22,713,175 | Jun 15 02:19 PM | | Corkal Bryan W.J. | Chief Financial Officer | Jun 15 | Sale | 18.77 | 5,093 | 95,613 | 73,307 | Jun 18 03:54 PM | | Arbadji Michel | Director of Business Developme | Jun 15 | Sale | 18.75 | 4,410 | 82,706 | 24,990 | Jun 18 03:43 PM | | Voytas Daniel F | Chief Science Officer | Jun 15 | Sale | 19.49 | 7,539 | 146,935 | 92,982 | Jun 15 06:31 PM | | Tripodi Federico A. | Chief Executive Officer | Jun 15 | Sale | 19.49 | 14,700 | 286,503 | 181,300 | Jun 15 06:28 PM | | Sahoo Manoj | Chief Commercial Officer | Jun 15 | Sale | 19.49 | 5,096 | 99,321 | 82,124 | Jun 15 06:22 PM | | Kozicz-Stankiewicz Anna Ewa | Director | Jun 15 | Sale | 19.49 | 1,000 | 19,490 | 18,600 | Jun 15 06:19 PM | | Dumont Philippe | Director | Jun 15 | Sale | 19.49 | 706 | 13,760 | 19,294 | Jun 15 06:15 PM | | Bowers Glenn R | Vice President of Breeding | Jun 15 | Sale | 19.49 | 423 | 8,244 | 8,617 | Jun 15 06:11 PM | | Choulika Andre | Director | Jun 15 | Sale | 19.49 | 2,352 | 45,840 | 154,448 | Jun 15 02:38 PM | | Voytas Daniel F | Chief Science Officer | May 21 | Option Exercise | 3.59 | 4,666 | 16,751 | 105,187 | May 23 03:16 PM | | Voytas Daniel F | Chief Science Officer | May 21 | Sale | 16.63 | 4,666 | 77,589 | 100,521 | May 23 03:16 PM | | Voytas Daniel F | Chief Science Officer | May 08 | Option Exercise | 3.71 | 4,083 | 15,165 | 104,604 | May 10 06:09 PM | | Voytas Daniel F | Chief Science Officer | May 08 | Sale | 15.58 | 4,083 | 63,596 | 100,521 | May 10 06:09 PM |
|
|
|
|
|
|
